Meet Our Founders
Christian Wasmer
Co-Founder and Managing Partner
Works across Medical Strategy, Clinical Planning, and New Product Planning for Pharma and Biotech clients, with a focus on oncology, rare disease, and metabolic disorders.
Over 10 years experience in advising clients; previously at Prescient Healthcare Group (Medical Advisory), Trinity Life Sciences (Strategic Advisory), Syneos Health (Advisory), and the Boston Consulting Group
Therapeutic area expertise in oncology (heme and solid tumors), rare genetic, metabolic and cardiovascular disorders
MSc in Physics (ETH Zurich), PhD/Doctorate (ETH Zurich) and PostDoc (Harvard Medical School) in oncology and neurology research
Friederike Winter
Co-Founder and Managing Partner
Works across Medical Strategy, Evidence Planning, and Approval Readiness for Pharma and Biotech clients, with a focus on oncology, rare disease, and neurology.
Over 8 years experience in advising clients, including at EY-Parthenon (Life Science Strategy), stradoo, and Prescient (Medical Advisory)
Therapeutic area expertise in solid tumors, heme-oncology, rare disease and neuro-immunology
MSc and DPhil (PhD) in Neuroscience from the University of Oxford, with a background in Molecular Medicine (University of Erlangen-Nürnberg)